Cargando…
Tu1255: SAFETY AND EFFICACY OF COVID-19 VACCINES IN PATIENTS WITH CIRRHOSIS: A CROSS SECTIONAL, OBSERVATIONAL STUDY
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212280/ http://dx.doi.org/10.1016/S0016-5085(22)63676-X |
_version_ | 1784730546616664064 |
---|---|
author | Singh, Virendra Singh, Amandeep De, Arka Singh, Mini P. Rathi, Sahaj Verma, Nipun Premkumar, Madhumita Taneja, Sunil Duseja, Ajay |
author_facet | Singh, Virendra Singh, Amandeep De, Arka Singh, Mini P. Rathi, Sahaj Verma, Nipun Premkumar, Madhumita Taneja, Sunil Duseja, Ajay |
author_sort | Singh, Virendra |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9212280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AGA Institute. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92122802022-06-22 Tu1255: SAFETY AND EFFICACY OF COVID-19 VACCINES IN PATIENTS WITH CIRRHOSIS: A CROSS SECTIONAL, OBSERVATIONAL STUDY Singh, Virendra Singh, Amandeep De, Arka Singh, Mini P. Rathi, Sahaj Verma, Nipun Premkumar, Madhumita Taneja, Sunil Duseja, Ajay Gastroenterology AASLD Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212280/ http://dx.doi.org/10.1016/S0016-5085(22)63676-X Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | AASLD Abstracts Singh, Virendra Singh, Amandeep De, Arka Singh, Mini P. Rathi, Sahaj Verma, Nipun Premkumar, Madhumita Taneja, Sunil Duseja, Ajay Tu1255: SAFETY AND EFFICACY OF COVID-19 VACCINES IN PATIENTS WITH CIRRHOSIS: A CROSS SECTIONAL, OBSERVATIONAL STUDY |
title | Tu1255: SAFETY AND EFFICACY OF COVID-19 VACCINES IN PATIENTS WITH CIRRHOSIS: A CROSS SECTIONAL, OBSERVATIONAL STUDY |
title_full | Tu1255: SAFETY AND EFFICACY OF COVID-19 VACCINES IN PATIENTS WITH CIRRHOSIS: A CROSS SECTIONAL, OBSERVATIONAL STUDY |
title_fullStr | Tu1255: SAFETY AND EFFICACY OF COVID-19 VACCINES IN PATIENTS WITH CIRRHOSIS: A CROSS SECTIONAL, OBSERVATIONAL STUDY |
title_full_unstemmed | Tu1255: SAFETY AND EFFICACY OF COVID-19 VACCINES IN PATIENTS WITH CIRRHOSIS: A CROSS SECTIONAL, OBSERVATIONAL STUDY |
title_short | Tu1255: SAFETY AND EFFICACY OF COVID-19 VACCINES IN PATIENTS WITH CIRRHOSIS: A CROSS SECTIONAL, OBSERVATIONAL STUDY |
title_sort | tu1255: safety and efficacy of covid-19 vaccines in patients with cirrhosis: a cross sectional, observational study |
topic | AASLD Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212280/ http://dx.doi.org/10.1016/S0016-5085(22)63676-X |
work_keys_str_mv | AT singhvirendra tu1255safetyandefficacyofcovid19vaccinesinpatientswithcirrhosisacrosssectionalobservationalstudy AT singhamandeep tu1255safetyandefficacyofcovid19vaccinesinpatientswithcirrhosisacrosssectionalobservationalstudy AT dearka tu1255safetyandefficacyofcovid19vaccinesinpatientswithcirrhosisacrosssectionalobservationalstudy AT singhminip tu1255safetyandefficacyofcovid19vaccinesinpatientswithcirrhosisacrosssectionalobservationalstudy AT rathisahaj tu1255safetyandefficacyofcovid19vaccinesinpatientswithcirrhosisacrosssectionalobservationalstudy AT vermanipun tu1255safetyandefficacyofcovid19vaccinesinpatientswithcirrhosisacrosssectionalobservationalstudy AT premkumarmadhumita tu1255safetyandefficacyofcovid19vaccinesinpatientswithcirrhosisacrosssectionalobservationalstudy AT tanejasunil tu1255safetyandefficacyofcovid19vaccinesinpatientswithcirrhosisacrosssectionalobservationalstudy AT dusejaajay tu1255safetyandefficacyofcovid19vaccinesinpatientswithcirrhosisacrosssectionalobservationalstudy |